Mucoadhesive chitosan-coated PLGA nanoparticles for oral delivery of ferulic acid

Artificial Cells, Nanomedicine, and Biotechnology
Isabela Angeli de LimaRubiana Mara Mainardes

Abstract

This paper describes the development and in vitro evaluation of poly(lactic-co-glycolic acid) (PLGA) nanoparticles coated with chitosan (CS) for oral delivery of ferulic acid (FA). Nanoparticles were obtained by an emulsion evaporation technique and characterized. Furthermore, we evaluated the scavenging activity over hypochlorous acid (HOCl), the cytotoxicity over tumour cells and the in vitro intestinal permeability. Nanoparticles were spherical with a mean diameter of 242 nm, positive zeta potential and 50% of encapsulation efficiency. The in vitro release in phosphate buffered saline (PBS) (pH 7.4) demonstrated a prolonged and biphasic profile diffusion-controlled. In simulated gastrointestinal fluids, about 15% of FA was released in gastric fluid and a negligible release was observed in the intestinal fluid. In the HOCl scavenging activity and cytotoxicity over B16-F10 and HeLa cells, FA-loaded nanoparticles presented the same efficacy of the free drug. Besides, in the antioxidant and cytotoxic assay, CS contributed to FA effects. In the intestinal permeability study, FA-loaded nanoparticles exhibited a permeation of 6% through the Caco-2 monolayer and 20% through the Caco-2/HT29-MTX/Raji B co-culture. CS-coated PLGA nanop...Continue Reading

References

Feb 1, 2003·International Journal of Biological Macromolecules·Caiqin QinXiaohai Gao
Feb 16, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·X Y XiongL H Gan
Dec 24, 2005·Expert Opinion on Drug Delivery·Hamidreza Montazeri Aliabadi, Afsaneh Lavasanifar
Jan 3, 2006·Proceedings of the National Academy of Sciences of the United States of America·Sayuri MiyamotoPaolo Di Mascio
Jun 9, 2006·Bioorganic & Medicinal Chemistry Letters·Lifeng Qi, Zirong Xu
Jul 20, 2006·Journal of Agricultural and Food Chemistry·Bolleddula JayaprakasamMuraleedharan G Nair
Jul 8, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Chunqiang Guo, Richard A Gemeinhart
May 20, 2009·International Journal of Pharmaceutics·Noha NafeeClaus-Michael Lehr
Oct 23, 2010·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jin Dai, Russell J Mumper
Sep 29, 2011·European Journal of Pharmacology·Suphiya Parveen, Sanjeeb K Sahoo
Nov 20, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Filipa AntunesBruno Sarmento
Dec 25, 2012·Colloids and Surfaces. B, Biointerfaces·Laura ChronopoulouCleofe Palocci
Oct 15, 2013·International Journal of Pharmaceutics·Francisca Araújo, Bruno Sarmento
Jan 1, 2014·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Cesare Mancuso, Rosaria Santangelo
Jan 22, 2014·International Journal of Biological Macromolecules·Jun LiuChang-hai Jin
Oct 11, 2014·Advances in Food and Nutrition Research·Dai-Hung Ngo, Se-Kwon Kim
Feb 18, 2015·Materials Science & Engineering. C, Materials for Biological Applications·Guo-Chung DongFeng-Huei Lin
Apr 14, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Marlene LopesHélder A Santos
Jan 24, 2017·Colloids and Surfaces. B, Biointerfaces·Daniella S SilvaBruno Sarmento
May 21, 2017·International Journal of Biological Macromolecules·Chen Li, Jian-Bin Li
Sep 16, 2014·Biotechnology Reports·Naresh Kumar, Vikas Pruthi
Jul 29, 2017·Advanced Drug Delivery Reviews·Anna LechanteurBruno Sarmento
Aug 12, 2017·Colloids and Surfaces. B, Biointerfaces·Maria MirAsim Ur Rehman
Nov 11, 2017·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Luíse L ChavesSalette Reis
Mar 3, 2018·Mycopathologia·Daniel Brustolin LudwigRubiana Mara Mainardes

❮ Previous
Next ❯

Citations

Sep 7, 2019·Drug Development and Industrial Pharmacy·Behiye Şenel, A Alper Öztürk
Jul 15, 2020·Pharmaceutics·Nabil A AlhakamyAshraf B Abdel-Naim
Feb 17, 2019·Environmental Science and Pollution Research International·Vinícius Silva LimaGuilherme Malafaia
Mar 3, 2020·Frontiers in Bioengineering and Biotechnology·Divesha EssaViness Pillay
Jun 6, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Genice IurckeviczMário A A da Cunha
Mar 27, 2020·International Journal of Molecular Sciences·Saikat DewanjeeVincenzo De Feo
Jul 28, 2020·Pharmaceutics·Anastasia DetsiPanagiotis Zoumpoulakis
Oct 31, 2020·Clinical and Experimental Pharmacology & Physiology·Abdifetah Ibrahim OmarKesara Na-Bangchang
Jan 16, 2021·International Journal of Biological Macromolecules·Emilli AntonioRubiana Mara Mainardes
Aug 21, 2020·International Journal of Pharmaceutics·Aikaterini-Theodora ChatzitakiOlga Borges
Jan 9, 2021·International Journal of Biological Macromolecules·Darshan R TelangeNilesh R Rarokar
Sep 26, 2020·Neurochemistry International·Rugmani Meenambal, M M Srinivas Bharath
Jul 1, 2020·International Journal of Biological Macromolecules·Elaheh FakhriHossein Samadi Kafil
May 1, 2021·Vaccines·Jennifer Schwestka, Eva Stoger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.